Hospital
Sturgis Hospital, INC.
Sturgis Hospital, INC. was paid $7.40M by Medicaid between Jan 2018 and Dec 2024, across 154 billing codes. Its largest line is 99285, emergency room visit (most serious) — 28% of everything it billed.
33Billing provider infoSTURGIS HOSPITAL, INC.
STURGIS, MI 49091
STURGIS, MI 49091
33aNPI1598099699assigned 09/23/2009
33bProvider typeRural Acute Care Hospital
28Total paid$7.40M
24GClaims230,811
24DCodes billed154
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Michigan
Rank by total paid#5 of 5
Median peer was paid$13.93M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,402 | $1.10M | |
| 2019 | 33,935 | $930K | |
| 2020 | 28,818 | $840K | |
| 2021 | 37,297 | $1.25M | |
| 2022 | 35,135 | $1.22M | |
| 2023 | 31,961 | $1.11M | |
| 2024incomplete | 25,263 | $956K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28% | 6,073 | 5,753 | $2.06M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 11,262 | 10,801 | $1.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 5,905 | 5,630 | $1.07M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6.1% | 9,436 | 3,559 | $451K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 3,740 | 3,519 | $366K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.4% | 1,576 | 1,530 | $251K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 7,015 | 2,192 | $218K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 2,211 | 2,186 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 1,475 | 1,199 | $138K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 3,430 | 3,345 | $131K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 3,164 | 2,874 | $102K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.0% | 3,932 | 3,807 | $75K |
142 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 1,705 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,305 | $55K |
| G0378 | Hospital observation service, per hour | <1% | 586 | $53K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,845 | $51K |
| 80053 | Comprehensive metabolic panel | <1% | 16,648 | $48K |
| 80061 | Lipid panel | <1% | 6,045 | $47K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,098 | $43K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 384 | $41K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,763 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,760 | $41K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,055 | $34K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 414 | $27K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,665 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,787 | $24K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 418 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,313 | $22K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 683 | $20K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 297 | $20K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 367 | $18K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 27 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,011 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,556 | $13K |
| 87070 | <1% | 3,777 | $13K | |
| 97161 | <1% | 216 | $11K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 469 | $10K |
| 76830 | Ultrasound, transvaginal | <1% | 166 | $10K |
| 82607 | <1% | 1,269 | $9K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 163 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 40 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,070 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,883 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 169 | $7K |
| 73130 | <1% | 550 | $7K | |
| 82728 | <1% | 913 | $6K | |
| 73630 | <1% | 420 | $6K | |
| 73610 | <1% | 396 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 55 | $6K |
| 83550 | <1% | 1,106 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,388 | $5K |
| 83880 | <1% | 723 | $5K | |
| 83540 | <1% | 1,400 | $5K | |
| 86003 | <1% | 87 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,023 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,016 | $4K |
| 87186 | <1% | 1,358 | $4K | |
| 80055 | <1% | 153 | $4K | |
| 87077 | <1% | 1,062 | $3K | |
| 84702 | <1% | 662 | $3K | |
| 73562 | <1% | 165 | $3K | |
| 73110 | <1% | 188 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,970 | $3K |
| 87088 | <1% | 907 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 199 | $3K |
| 73564 | <1% | 55 | $2K | |
| 84439 | <1% | 499 | $2K | |
| 86900 | <1% | 92 | $2K | |
| 81001 | <1% | 5,218 | $2K | |
| 86769 | <1% | 71 | $2K | |
| 85610 | <1% | 1,738 | $2K | |
| 83735 | <1% | 2,611 | $2K | |
| 84403 | <1% | 235 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $2K |
| 85651 | <1% | 1,017 | $2K | |
| 73030 | <1% | 107 | $2K | |
| 72110 | <1% | 41 | $2K | |
| 86140 | <1% | 1,026 | $1K | |
| 81003 | <1% | 3,766 | $1K | |
| 84481 | <1% | 413 | $1K | |
| 87420 | <1% | 757 | $992.78 | |
| 81002 | <1% | 617 | $967.80 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,193 | $965.40 |
| 80305 | <1% | 813 | $958.57 | |
| 83690 | <1% | 2,886 | $946.90 | |
| 93017 | <1% | 55 | $946.10 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 20 | $849.40 |
| 84153 | <1% | 93 | $847.56 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $796.14 |
| 84703 | <1% | 408 | $758.73 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 49 | $732.29 |
| 74018 | <1% | 28 | $707.86 | |
| 84436 | <1% | 194 | $705.79 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 142 | $646.53 |
| 76801 | <1% | 12 | $623.48 | |
| 82627 | <1% | 70 | $590.66 | |
| 97162 | <1% | 13 | $588.12 | |
| 82550 | <1% | 385 | $543.87 | |
| 84484 | <1% | 2,471 | $485.15 | |
| 84144 | <1% | 43 | $458.43 | |
| 86665 | <1% | 74 | $456.76 | |
| 87081 | <1% | 106 | $387.17 | |
| 82670 | <1% | 52 | $372.71 | |
| 82746 | <1% | 44 | $345.40 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 120 | $294.49 |
| 82784 | <1% | 75 | $292.40 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $271.63 |
| 83001 | <1% | 54 | $253.66 | |
| 82950 | <1% | 87 | $238.86 | |
| 86664 | <1% | 37 | $223.67 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 556 | $223.41 |
| 80076 | <1% | 108 | $218.74 | |
| 86663 | <1% | 37 | $214.29 | |
| 81025 | <1% | 3,252 | $207.87 | |
| 85018 | <1% | 160 | $206.57 | |
| 86008 | <1% | 56 | $200.51 | |
| 87660 | <1% | 24 | $197.40 | |
| 87510 | <1% | 24 | $197.40 | |
| 87480 | <1% | 24 | $197.40 | |
| 82044 | <1% | 65 | $185.82 | |
| 86038 | <1% | 39 | $146.83 | |
| 80074 | <1% | 13 | $140.49 | |
| 83655 | <1% | 26 | $129.57 | |
| 85378 | <1% | 311 | $126.18 | |
| 85730 | <1% | 377 | $116.60 | |
| 83605 | <1% | 1,080 | $80.03 | |
| 86592 | <1% | 42 | $68.46 | |
| 82150 | <1% | 200 | $60.95 | |
| 87076 | <1% | 20 | $42.65 | |
| 87040 | <1% | 41 | $18.17 | |
| 82040 | <1% | 28 | $17.92 | |
| 84100 | <1% | 15 | $11.28 | |
| 86850 | <1% | 51 | $6.67 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,508 | $2.54 |
| 86901 | <1% | 106 | $2.27 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 1,152 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,716 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,202 | $0.00 |
| 90715 | 0% | 30 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 323 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 143 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 56 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 16 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,577 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 141 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 528 | $0.00 |
| 96376 | 0% | 88 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 402 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 28 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 257 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 121 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 25 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 73 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORIN, ROBERT (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Sturgis Hospital, INC. | Sturgis, MI | $323K |
| Sturgis Hospital, INC. | Constantine, MI | $25K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.